Par Drugs and Chemicals Limited

NSE PAR.NS

Par Drugs and Chemicals Limited Return on Equity (ROE) for the year ending March 31, 2024

Par Drugs and Chemicals Limited Return on Equity (ROE) is NA for the year ending March 31, 2024. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Par Drugs and Chemicals Limited Return on Equity (ROE) for the year ending March 31, 2023 was 15.91%, a 3.40% change year over year.
Par Drugs and Chemicals Limited Return on Equity (ROE) for the year ending March 31, 2022 was 15.39%, a -30.81% change year over year.
Par Drugs and Chemicals Limited Return on Equity (ROE) for the year ending March 31, 2021 was 22.24%, a 89.54% change year over year.
Par Drugs and Chemicals Limited Return on Equity (ROE) for the year ending March 31, 2020 was 11.73%, a 41.23% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

NSE: PAR.NS

Par Drugs and Chemicals Limited

CEO	Mr. Jignesh Vallabhbhai Savani
IPO Date	May 30, 2019
Location	India
Headquarters	816, Nilamber Triumph
Employees	122
Sector	Materials
Industries Glass Chemicals & Advanced Materials Cleaning Supplies Composite Materials Cosmetics Personal Care Petrochemicals Plastics

Description

Par Drugs and Chemicals Limited develops, produces, and sells active pharma ingredients and fine chemicals in India. It offers magnesium salts, dried aluminum hydroxide gel, sodium aluminum silicate, precipitated silica, magnesium silicate, colloidal silicon dioxide, sucralfate USP, and amorphous and blended products. The company also exports its products. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.

Key trends

Past 5 years